Genetix has announced that Vanderbilt Monoclonal Antibody Core (VMAC), Vanderbilt University, has become the 100th facility to purchase its Clonepix FL system.
Used for screening and selection of secretory cell lines, the Clonepix FL system is said to significantly reduce the time and costs associated with recombinant protein generation.
VMAC will use the system to support its monoclonal and polyclonal antibody generation, purification and characterisation technical advice and services, and also its recombinant protein-production and purification services.
